CIBA 24 (Cytadren 250 mg)
Generic Name: aminoglutethimide
Pill with imprint CIBA 24 is White, Round and has been identified as Cytadren 250 mg. It is supplied by Novartis Pharmaceuticals.
Cytadren is used in the treatment of breast cancer; cushing's syndrome; prostate cancer and belongs to the drug class adrenal corticosteroid inhibitors. There is positive evidence of human fetal risk during pregnancy. Cytadren 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CIBA 24
Cytadren
- Generic Name
- aminoglutethimide
- Imprint
- CIBA 24
- Strength
- 250 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Adrenal corticosteroid inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00083-0024 (Discontinued)
More about Cytadren (aminoglutethimide)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Drug class: adrenal corticosteroid inhibitors
Patient resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.